These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6188292)

  • 41. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
    Olsson R; Roos BE
    Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
    [No Abstract]   [Full Text] [Related]  

  • 42. Rapid elevation of biogenic amine metabolites in human CSF following probenecid.
    Tamarkin NR; Goodwin FK; Axelrod J
    Life Sci I; 1970 Dec; 9(24):1397-408. PubMed ID: 5493322
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of locally infused serotonin on canine forelimb weight and segmental vascular resistance.
    Merrill GF; Kline RL; Haddy FJ; Grega GJ
    J Pharmacol Exp Ther; 1974 Apr; 189(1):140-8. PubMed ID: 4823288
    [No Abstract]   [Full Text] [Related]  

  • 44. A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant.
    van Praag HM; Korf J; Dols LC; Schut T
    Psychopharmacologia; 1972; 25(1):14-21. PubMed ID: 4556909
    [No Abstract]   [Full Text] [Related]  

  • 45. Modification of intestinal stimulatory effects of 5-hydroxytryptamine by adrenergic amines, prostaglandin E1 and theophylline.
    Grubb MN; Burks TF
    J Pharmacol Exp Ther; 1974 May; 189(2):476-83. PubMed ID: 4364199
    [No Abstract]   [Full Text] [Related]  

  • 46. The elimination of 5-hydroxyindoleacetic acid from cerebrospinal fluid: characteristics of the acid transport system of the choroid plexus.
    Sampath SS; Neff NH
    J Pharmacol Exp Ther; 1974 Feb; 188(2):410-4. PubMed ID: 4359553
    [No Abstract]   [Full Text] [Related]  

  • 47. Inflammation induced by histamine, serotonin, bradykinin and compound 48-80 in the rat: antagonists and mechanisms of action.
    Maling HM; Webster ME; Williams MA; Saul W; Anderson W
    J Pharmacol Exp Ther; 1974 Nov; 191(2):300-10. PubMed ID: 4153590
    [No Abstract]   [Full Text] [Related]  

  • 48. Mechanism of the indirect sympathomimetic effect of 5-hydroxytrypt-amine on the isolated heart of the rabbit.
    Fozard JR; Mwaluko GM
    Br J Pharmacol; 1976 May; 57(1):115-25. PubMed ID: 1276530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular tone and reactivity to serotonin in the internal and external carotid vascular beds of the dog.
    Vidrio H; Hong E
    J Pharmacol Exp Ther; 1976 Apr; 197(1):49-56. PubMed ID: 1263132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacodynamics of 5-hydroxytryptamine uptake and metabolism by the isolated perfused rabbit lung.
    Pickett RD; Anderson MW; Orton TC; Eling TE
    J Pharmacol Exp Ther; 1975 Sep; 194(3):545-53. PubMed ID: 1159631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the effect of 5-hydroxykynurenamine,, a serotonin metabolite, on isolated cerebral arteries, aortas and atria.
    Toda N
    J Pharmacol Exp Ther; 1975 May; 193(2):385-92. PubMed ID: 1142096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary disposition of serotonin in the intact animal.
    Buckpitt AR; Maickel RP; Bosin TR
    Biochem Pharmacol; 1978 Feb; 27(4):569-74. PubMed ID: 629817
    [No Abstract]   [Full Text] [Related]  

  • 53. Release of serotonin from mast cells induced by N-(2-ethylhexyl)-3-hydroxybutyramide and catecholamine.
    Ichikawa A; Kaneko H; Mori Y; Tomita K
    Biochem Pharmacol; 1977 Feb; 26(3):197-202. PubMed ID: 66055
    [No Abstract]   [Full Text] [Related]  

  • 54. [Behavior of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in relation to agonized suffering (I)].
    Luna A; Villanueva E; Hernandez-Cueto C; Luna JD
    Z Rechtsmed; 1983; 89(4):215-26. PubMed ID: 6188292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of flavonols on emotional behavior and compounds of the serotonergic system: A preclinical systematic review.
    Mendonça CR; Manhães-de-Castro R; de Santana BJRC; Olegário da Silva L; Toscano AE; Guzmán-Quevedo O; Galindo LCM
    Eur J Pharmacol; 2022 Feb; 916():174697. PubMed ID: 34954234
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.